| Anti-alcohol medication and pregnancy: weighing the risks. | |
| | |
MedLine Citation:
|
PMID: 22413725 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
When there is a major risk of alcohol withdrawal symptoms in a pregnant woman, a 7-day course of benzodiazepine therapy has a positive harm-benefit balance. Medications designed to help maintain abstinence are not sufficiently effective to warrant initiating treatment during pregnancy. |
| | |
Authors:
|
- |
Related Documents
:
|
12408635 - Tributyltin and triphenyltin induce spermatogenesis in ovary of female abalone, halioti... 19111675 - Targeted disruption of the mouse lipoma preferred partner gene. 4056295 - Ectoparasitic infestation of the lashes. 7535255 - Identification, characterisation, and measurement of immunoglobulin concentrations in g... 22439075 - Antiphospholipid syndrome during pregnancy: the state of the art. 14981395 - Genetic influence on prolonged gestation: a population-based danish twin study. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Prescrire international Volume: 21 ISSN: 1167-7422 ISO Abbreviation: Prescrire Int Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-03-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9439295 Medline TA: Prescrire Int Country: France |
Other Details:
|
Languages: eng Pagination: 48 Citation Subset: T |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pregnancy: another opportunity to raise the issue of alcohol.
Next Document: Learning from errors: a workshop for personal and collective reflection.